Drug Discovery (Phylogica)

The Drug Discovery Technology Group and Phylogica, commercialisation vehicle.


Addressing emerging needs of the Pharmaceutical industry

PhylogicaThe Drug Discovery Technology Group is focused on developing new therapies to target disease-causing interactions between proteins; both inside and outside of cells, especially targets driving childhood cancer.

The research of the unit is funded by contracts with several large pharmaceutical companies via a commercial entity named 'Phylogica,' which was the first spin-off company from the Telethon Kids Institute.

Listed on the Australian Stock Exchange, Phylogica (PYC) is a specialist drug discovery company, which identifies new prototype drugs for large drug company customers.  It achieves this by drawing from its own source of billions of unique natural peptide compounds - a new drug class known as "Phylomers".

This collection of more than 400 billion compounds is the source of its potential new drugs and access to this asset is what has driven deals and strategic alliances with the international pharmaceutical giants Roche, MedImmune (AstraZeneca), Pfizer, Janssen Biotech (Johnson &Johnson) and Genetech within the last five years.

These unique collections of Phylomer peptides are strongly protected by a portfolio of 18 patent families, including granted patents in the US and Europe. 

Team Members

Dr Douglas Wilson, Executive Chairman

Dr Graham Boden. CFO

Dr Richard Hopkins, Program Manager- Drug Discovery Unit. CEO Phylogica.

Dr Paul Watt, Senior Principal Program Manager & Head of Drug Discovery Unit.  CSO Phylogica

Dr Katrin Hoffmann, Associate Program Manager - Drug Discovery Unit.  Director of Research Operations - Phylogica

Dr Paula Cunningham, Senior Research Officer - Drug Discovery Unit.  Group Leader, Bioassay Development - Phylogica

Dr Tatjana Heinrich, Associate Program Manager - Drug Discovery Unit.   Group Leader, Intracellular Screening and Library Development
- Phylogica 

Dr Nadia Milech, Associate Program Manager - Drug Discovery Unit.   Group Leader, Intracellular Screening and Library Development
- Phylogica 

Senior Scientists, Drug Discovery

Dr Renae Barr

Dr Heique Bogdawa

Dr Rob Dewhurst

Mr Richard Francis

Dr Suzy Juraja

Dr Brooke Longville

Dr Shane Stone

Dr Yew-Foon Tan


Research Scientists

Mr Mark Anastasas 

Ms Laura Florez

Ms Maria Kerfoot

Mr Ferrer Ong 

Ms Marie Scobie , Lab Manager

Mr Scott Winslow


Laboratory Technician

Ms Leanne Neville


Administrative Support

Ms Farzana Khan, Office Manager

Ms Angela Purkiss, Administrative Assistant

Subscribe to our e-news

Mailing list terms and Conditions

By subscribing to this service you are giving Telethon Kids Institute permission to contact you direct via email. You may unsubscribe at anytime via the emails sent to you.

Your email address will not be disclosed to any third party.

Please agree with the Terms & Conditions.